Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments

Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s … khnjonela Kaiser Health News

As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that federal health officials warn no longer work against the highly contagious version of the virus that causes covid-19. The antibody treatment now most recommended is sotrovimab from GlaxoSmithKline and Vir Biotechnology, and it’s in short supply...